GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Institutional Ownership

Rubius Therapeutics (STU:5RT) Institutional Ownership : 0.58% (As of Jun. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rubius Therapeutics's institutional ownership is 0.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rubius Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rubius Therapeutics's Float Percentage Of Total Shares Outstanding is 43.67%.


Rubius Therapeutics Institutional Ownership Historical Data

The historical data trend for Rubius Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Institutional Ownership Chart

Rubius Therapeutics Historical Data

The historical data trend for Rubius Therapeutics can be seen below:

2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30
Institutional Ownership 32.85 32.42 31.65 30.18 25.79 20.52 0.93 0.64 0.59 0.58

Rubius Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Rubius Therapeutics (STU:5RT) Business Description

Traded in Other Exchanges
N/A
Address
124 Washington Street, Suite 101, Foxborough, MA, USA, 02035
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines